Foveal thickness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema

Foveal thickness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema

AIM: To report foveal thickness reduction in eyes with resolution of macular edema and recovery of a foveal depression after one-year of anti-vascular endothelial growth factor (anti-VEGF) therapy for center-involving diabetic macular edema (DME). METHODS: Foveal thickness was assessed with optical...

Full description

Bibliographic Details
Main Authors: Gabriel Willmann, Antonio Brunno Nepomuceno, Katharina Messias, Leticia Barroso, Ingrid U. Scott, André Messias, Rodrigo Jorge
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2017-05-01
Series:International Journal of Ophthalmology
Subjects:
764
diabetes
macular edema
bevacizumab
ranibizumab
optical coherence tomography
central subfield foveal thickness
diabetic retinopathy
Online Access:http://www.ijo.cn/en_publish/2017/5/20170517.pdf

Internet

http://www.ijo.cn/en_publish/2017/5/20170517.pdf

Similar Items